Two-Weekly or Three-Weekly CHOP Chemotherapy with or without Etoposide for the Treatment of Young Patients with Good-Prognosis (Normal LDH) Aggressive Lymphomas:Results of the NHL-B1 Trial of the DSHNHL

• 2周或3周CHOP加或不加依托泊苷治疗无不良预后因素(LDH正常)年轻侵袭性淋巴瘤NHL-B1临床试验结果